Abstract
We compared urinary levels of cytokines in patients with and without albuminuria, proteinuria and kidney disease (glomerular filtration rate<60 mL/min per 1.73 m2) after HCT. Plasma and urine were collected at baseline and weekly through day 100 and monthly through year 1, for measurement of IL-6, gp130, sIL6r, IL-10, IL15, MCP-1 and urine albumin-to-creatinine ratios (ACRs). Cox-proportional hazards modeling examined associations between urinary cytokine levels and development of these renal end points. The association of ACR with the hazard of overall mortality was assessed using Cox regression. Increasing urinary IL-6 and IL-15 were associated with an increased risk of developing proteinuria. Urinary MCP-1 during the first 100 days post HCT was associated with kidney disease at 1 year. The degree of albuminuria at any time point in the first 100 days post transplant was related to the subsequent risk of death (for ACR 30–299, hazard ratio (HR)=1.91; 95% confidence interval (CI): 1.27–2.87; for ACR >300, HR=2.82; 95% CI: 1.60–4.98). After HCT, elevated urinary levels of pro-inflammatory cytokines are associated with development of albuminuria and proteinuria, suggesting early intra-renal inflammation as an important pathogenetic mechanism. Albuminuria and proteinuria within the first 100 days post HCT are associated with decreased overall survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cohen EP, Lawton CA, Moulder JE . Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 1995; 70: 217–222.
Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB . Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223–229.
Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR . Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6: 89–94.
Guinan EC, Tarbell NJ, Niemeyer CM, Sallan SE, Weinstein HJ . Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72: 451–455.
Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE . End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 1998; 79: 408–412.
Carella AM, Champlin R, Slavin S, McSweeney P, Storb R . Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 2000; 25: 345–350.
Doroshow JHaS TW . Pharmacologic basis for high-dose chemotherapy. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 289–315.
Leather HL, Wingard JR . Bacterial infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1325–1345.
Zaia JA . Cytomegalovirus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1367–1381.
Brown JMY . Fungal infections after hematopoietic cell transplantation. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, Wiley-Blackwell: Malden, UK, 2009 pp 1346–1366.
Brown JWMY . Fungal infections after hematopoietic cell transplantation. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1346–1366.
Ito J . Herpes simplex virus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1382–1387.
Ho DY, Arvin AM . Varicella-zoster virus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, Wiley-Blackwell: Malden, UK, 2009 pp 1388–1409.
Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977–1983.
Edward J Roccella for National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576.
Kishimoto T . IL-6: from its discovery to clinical applications. Int Immunol 2010; 22: 347–352.
Harada K, Akai Y, Kurumatani N, Iwano M, Saito Y . Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study. Nephron 2002; 92: 824–826.
Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH et al. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 2008; 19: 789–797.
Fehniger TA, Caligiuri MA . Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14–32.
Shinozaki M, Hirahashi J, Lebedeva T, Liew FY, Salant DJ, Maron R et al. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Investig 2002; 109: 951–960.
Weiler M, Rogashev B, Einbinder T, Hausmann MJ, Kaneti J, Chaimovitz C et al. Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. J Am Soc Nephrol 1998; 9: 1194–1201.
Zager RA, Johnson AC, Becker K . Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and “end-stage” kidney disease. Am J Physiol Renal Physiol 2011; 301: F1334–F1345.
Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM et al. MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 2011; 22: 165–175.
Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492–1499.
Couriel D, Caldera H, Champlin R, Komanduri K . Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936–1946.
Krenger W, Hill GR, Ferrara JL . Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553–558.
Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H et al. Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 303–306.
Seconi J, Watt V, Ritchie DS . Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 2003; 32: 447–450.
Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575–581.
Hingorani SR, Seidel K, Lindner A, Aneja T, Schoch G, McDonald G . Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 2008; 14: 1365–1372.
Acknowledgements
This research was supported by the National Institutes of Health (NIDDK) 1R01DK080860-01. Chronic kidney disease in survivors of hematopoietic cell transplant received by Dr Hingorani.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hingorani, S., Gooley, T., Pao, E. et al. Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant 49, 403–409 (2014). https://doi.org/10.1038/bmt.2013.197
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.197
Keywords
This article is cited by
-
Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation (2024)
-
Glomerulonephritis: immunopathogenesis and immunotherapy
Nature Reviews Immunology (2023)
-
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant
Pediatric Nephrology (2022)
-
Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure
Scientific Reports (2021)
-
Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis
Bone Marrow Transplantation (2021)